No recommendation from NTAGI yet on inoculating children: NITI member

There has been no recommendation yet from the National Technical Advisory Group on Immunization (NTAGI) on vaccinating children against COVID-19, NITI Aayog Member (Health) Dr V K Paul said Friday

vaccine
Press Trust of India New Delhi
1 min read Last Updated : Dec 10 2021 | 7:10 PM IST

There has been no recommendation yet from the National Technical Advisory Group on Immunization (NTAGI) on vaccinating children against COVID-19, NITI Aayog Member (Health) Dr V K Paul said Friday.

"The team has been examining information coming from several sources in this regard," he told a press conference here.

He said the NTAGI meets often where science is being "looked at systematically, carefully. We do not have any recommendations on pediatric vaccination from them as yet. They are examining it and other facets of vaccines," he said.

On a question on Covid booster doses for adults, Paul said, "We are keeping an eye on global scientific studies in this regard."

There is no stand of the World Health Organization on booster doses, he said.

"It is under consideration. But the WHO has clearly highlighted the need for completing primary vaccination as the most important priority and our thinking, view is also aligned with the same approach that we have to complete the task of vaccinating all individual with both doses.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineVaccinationchildren

First Published: Dec 10 2021 | 7:10 PM IST

Next Story